How analysts are interpreting Biogen's management shakeup
June 14, 2017 at 13:03 PM EDT
The Cambridge drugmaker has lost several top executives since getting a new CEO in January, hinting that bigger changes could be afoot.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|